Phase II study of ramucirumab and docetaxel for previously treated non‐small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study

INTRODUCTION: Anti‐vascular endothelial growth factor therapy has been shown to be effective in non‐small cell lung cancer (NSCLC) patients with malignant pleural effusion (MPE); however, there are no data to suggest that ramucirumab has the same effects. METHODS: We therefore decided to conduct a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Takemoto, Shinnosuke, Fukuda, Minoru, Yamaguchi, Hiroyuki, Ikeda, Takaya, Akagi, Kazumasa, Tomono, Hiromi, Umeyama, Yasuhiro, Dotsu, Yosuke, Taniguchi, Hirokazu, Gyotoku, Hiroshi, Senju, Hiroaki, Kitazaki, Takeshi, Nakatomi, Katsumi, Nagashima, Seiji, Fukuda, Masaaki, Kinoshita, Akitoshi, Soda, Hiroshi, Mukae, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996979/
https://www.ncbi.nlm.nih.gov/pubmed/31851428
http://dx.doi.org/10.1111/1759-7714.13279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996979/
https://www.ncbi.nlm.nih.gov/pubmed/31851428
http://dx.doi.org/10.1111/1759-7714.13279

Ejemplares similares